Characterization of cystic fibrosis airway epithelium in vitro

S. M. Stick, A. Kicic, E. N. Sutanto, A. Fonceca, D. A. Knight (Perth, Nedlands, Australia; British Columbia, Canada)

Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Session: Cystic fibrosis lung disease: pieces of the puzzle
Session type: Oral Presentation
Number: 1632
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. M. Stick, A. Kicic, E. N. Sutanto, A. Fonceca, D. A. Knight (Perth, Nedlands, Australia; British Columbia, Canada). Characterization of cystic fibrosis airway epithelium in vitro. Eur Respir J 2005; 26: Suppl. 49, 1632

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis
Source: Eur Respir J 2012; 39: 297-304
Year: 2012



Mechanisms and markers of airway inflammation in cystic fibrosis
Source: Eur Respir J 2002; 19: 333-340
Year: 2002



Anti-inflammatory cytokines in cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: 581-587
Year: 2006



Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Source: Eur Respir J 2007; 29: 240-250
Year: 2007



Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction
Source: Eur Respir J 2004; 23: 846-850
Year: 2004



Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway
Source: Eur Respir J 2003; 21: 574-581
Year: 2003



M2 polarized alveolar macrophages in pulmonary fibrosis
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005


Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis
Source: Eur Respir J 2009; 34: 655
Year: 2009



Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium
Source: Eur Respir J 2013; 41: 1315-1323
Year: 2013



Investigation of the status of cystic fibrosis airway epithelial cells
Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy
Year: 2008


TLR-4 expression is reduced in cystic fibrosis bronchial epithelial cells
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008



Alveolar epithelial injury and apoptosis
Source: Annual Congress 2007 - Mechanisms in pulmonary fibrosis
Year: 2007

Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease
Source: Eur Respir J 2011; 37: 1378-1385
Year: 2011



The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013

Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011


The role of chemokines and cytokines in lung fibrosis
Source: Eur Respir Rev 2008; 17: 151-156
Year: 2008